--2023/Q40.000 / 0.000--
--2023/Q30.000 / 3.500M--
--2023/Q20.000 / 0.000--
--------
--------
Salesforce
CRM
Apple
AAPL
Microsoft
MSFT
Coinbase
COIN
Meta Platforms
META
US Stock MarketDetailed Quotes
COEP Coeptis Therapeutics
- 0.186
- +0.001+0.76%
Close Dec 12 16:00 ET
7.65MMarket Cap-0.66P/E (TTM)
0.200High0.175Low2.36MVolume0.200Open0.185Pre Close449.04KTurnover7.13%Turnover RatioLossP/E (Static)41.12MShares0.97052wk High1.59P/B6.15MFloat Cap0.15152wk Low--Dividend TTM33.04MShs Float21.420Historical High--Div YieldTTM13.54%Amplitude0.151Historical Low0.190Avg Price1Lot Size
Coeptis Therapeutics Key Stats
Coeptis Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Coeptis Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.